Finally, Ivey and colleagues found that minimal residual disease, which was detected by the presence of Nucleophosmin (NPM1)-mutated transcripts in normal mononuclear cells after achieving remission in AML, was one of the strongest predictors of relapse and carried a poor overall survival. Here, NPM1 is linked to acute myeloid leukemia.